{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T11:50:44Z","timestamp":1791719444681,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1124\/jpet.114.215228","type":"journal-article","created":{"date-parts":[[2014,8,29]],"date-time":"2014-08-29T03:50:11Z","timestamp":1409284211000},"page":"373-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Suramin Inhibits the Development and Progression of Peritoneal Fibrosis"],"prefix":"10.1016","volume":"351","author":[{"given":"Chongxiang","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shougang","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.114.215228_bib1","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1053\/j.ajkd.2005.08.011","article-title":"Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor","volume":"46","author":"Aroeira","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1124\/jpet.114.215228_bib2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s10875-005-7827-3","article-title":"Molecular aspects of regulation of collagen gene expression in fibrosis","volume":"25","author":"Bhogal","year":"2005","journal-title":"J Clin Immunol"},{"key":"10.1124\/jpet.114.215228_bib3","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ki.2013.303","article-title":"Biocompatible peritoneal dialysis solutions: many questions but few answers","volume":"84","author":"Blake","year":"2013","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.114.215228_bib4","first-page":"32","article-title":"Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model","volume":"24","author":"Bozkurt","year":"2008","journal-title":"Adv Perit Dial"},{"key":"10.1124\/jpet.114.215228_bib5","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1152\/japplphysiol.00915.2002","article-title":"Antifibrotic effects of suramin in injured skeletal muscle after laceration","volume":"95","author":"Chan","year":"2003","journal-title":"J Appl Physiol (1985)"},{"key":"10.1124\/jpet.114.215228_bib6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2215\/CJN.07920910","article-title":"Peritoneal dialysis first: rationale","volume":"6","author":"Chaudhary","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1124\/jpet.114.215228_bib7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-0028-1082388","article-title":"TGF-beta system: the principal profibrotic mediator of peritoneal adhesion formation","volume":"26","author":"Chegini","year":"2008","journal-title":"Semin Reprod Med"},{"key":"10.1124\/jpet.114.215228_bib8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.semnephrol.2011.01.006","article-title":"Determinants of peritoneal membrane function over time","volume":"31","author":"Davies","year":"2011","journal-title":"Semin Nephrol"},{"key":"10.1124\/jpet.114.215228_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cca.2013.02.027","article-title":"Inflammation, neoangiogenesis and fibrosis in peritoneal dialysis","volume":"421","author":"de Lima","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1124\/jpet.114.215228_bib10","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1681\/ASN.V1281734","article-title":"Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane","volume":"12","author":"De Vriese","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.114.215228_bib11","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1681\/ASN.2009070694","article-title":"The pathophysiology of the peritoneal membrane","volume":"21","author":"Devuyst","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.114.215228_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00467-007-0541-z","article-title":"Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis","volume":"23","author":"Fusshoeller","year":"2008","journal-title":"Pediatr Nephrol"},{"issue":"Suppl","key":"10.1124\/jpet.114.215228_bib13","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0092-8674(02)00703-1","article-title":"Missing pieces in the NF-kappaB puzzle","volume":"109","author":"Ghosh","year":"2002","journal-title":"Cell"},{"key":"10.1124\/jpet.114.215228_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cardiores.2003.09.033","article-title":"The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extended","volume":"61","author":"Herrmann","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1124\/jpet.114.215228_bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1476-4598-12-86","article-title":"The complexity of NF-\u03baB signaling in inflammation and cancer","volume":"12","author":"Hoesel","year":"2013","journal-title":"Mol Cancer"},{"key":"10.1124\/jpet.114.215228_bib16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/j.gastro.2012.09.059","article-title":"Activation of nuclear factor-\u03baB in acinar cells increases the severity of pancreatitis in mice","volume":"144","author":"Huang","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.114.215228_bib17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.18388\/abp.2005_3446","article-title":"TGF beta signalling and its role in tumour pathogenesis","volume":"52","author":"Kaminska","year":"2005","journal-title":"Acta Biochim Pol"},{"issue":"Suppl 2","key":"10.1124\/jpet.114.215228_bib18","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1177\/089686080702702s15","article-title":"Peritoneal fibrosis intervention","volume":"27","author":"Kaneko","year":"2007","journal-title":"Perit Dial Int"},{"key":"10.1124\/jpet.114.215228_bib19","doi-asserted-by":"crossref","first-page":"a000141","DOI":"10.1101\/cshperspect.a000141","article-title":"NF-kappaB as a critical link between inflammation and cancer","volume":"1","author":"Karin","year":"2009","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1124\/jpet.114.215228_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cbi.2011.11.002","article-title":"Epigallocatechin gallate suppresses peritoneal fibrosis in mice","volume":"195","author":"Kitamura","year":"2012","journal-title":"Chem Biol Interact"},{"key":"10.1124\/jpet.114.215228_bib22","doi-asserted-by":"crossref","first-page":"c11","DOI":"10.1159\/000314544","article-title":"Inflammation in peritoneal dialysis","volume":"116","author":"Lai","year":"2010","journal-title":"Nephron Clin Pract"},{"key":"10.1124\/jpet.114.215228_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cyto.2013.10.003","article-title":"Calcitriol decreases TGF-\u03b21 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats","volume":"65","author":"Lee","year":"2014","journal-title":"Cytokine"},{"key":"10.1124\/jpet.114.215228_bib24","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.2353\/ajpath.2009.090037","article-title":"Involvement of sphingosine 1-phosphate (SIP)\/S1P3 signaling in cholestasis-induced liver fibrosis","volume":"175","author":"Li","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1124\/jpet.114.215228_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/157488411796151174","article-title":"Tissue protective and anti-fibrotic actions of suramin: new uses of an old drug","volume":"6","author":"Liu","year":"2011","journal-title":"Curr Clin Pharmacol"},{"key":"10.1124\/jpet.114.215228_bib26","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1681\/ASN.2010090956","article-title":"Suramin inhibits renal fibrosis in chronic kidney disease","volume":"22","author":"Liu","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.114.215228_bib27","doi-asserted-by":"crossref","first-page":"e32009","DOI":"10.1371\/journal.pone.0032009","article-title":"A crosstalk between the Smad and JNK signaling in the TGF-\u03b2-induced epithelial-mesenchymal transition in rat peritoneal mesothelial cells","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1124\/jpet.114.215228_bib28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ki.5000054","article-title":"Renal fibrosis: new insights into the pathogenesis and therapeutics","volume":"69","author":"Liu","year":"2006","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.114.215228_bib29","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/0886022X.2013.844645","article-title":"Functional and structural alterations of peritoneum and secretion of fibrotic cytokines in rats caused by high glucose peritoneal dialysis solutions","volume":"36","author":"Liu","year":"2014","journal-title":"Ren Fail"},{"key":"10.1124\/jpet.114.215228_bib30","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13238-011-1089-z","article-title":"CUEDC2: an emerging key player in inflammation and tumorigenesis","volume":"2","author":"Man","year":"2011","journal-title":"Protein Cell"},{"key":"10.1124\/jpet.114.215228_bib31","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1681\/ASN.V12102029","article-title":"Gene transfer of transforming growth factor-beta1 to the rat peritoneum: effects on membrane function","volume":"12","author":"Margetts","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.114.215228_bib32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jat.1393","article-title":"NF-kappaB in liver diseases: a target for drug therapy","volume":"29","author":"Muriel","year":"2009","journal-title":"J Appl Toxicol"},{"key":"10.1124\/jpet.114.215228_bib33","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.semnephrol.2004.06.027","article-title":"Advanced glycation end-products and peritoneal sclerosis","volume":"24","author":"Nakamura","year":"2004","journal-title":"Semin Nephrol"},{"key":"10.1124\/jpet.114.215228_bib34","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3109\/0886022X.2012.676527","article-title":"Involvement of lymphocyte infiltration in the progression of mouse peritoneal fibrosis model","volume":"34","author":"Nishino","year":"2012","journal-title":"Ren Fail"},{"key":"10.1124\/jpet.114.215228_bib35","doi-asserted-by":"crossref","first-page":"F996","DOI":"10.1152\/ajprenal.00282.2009","article-title":"Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy","volume":"297","author":"Pang","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/jpet.114.215228_bib36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ki.2009.436","article-title":"Smad3-dependent and -independent pathways are involved in peritoneal membrane injury","volume":"77","author":"Patel","year":"2010","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.114.215228_bib37","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1093\/ndt\/gfm323","article-title":"Inhibitory effects of matrix metalloproteinase inhibitor ONO-4817 on morphological alterations in chlorhexidine gluconate-induced peritoneal sclerosis rats","volume":"22","author":"Ro","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1124\/jpet.114.215228_bib38","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00467-007-0580-5","article-title":"Pathogenesis and treatment of peritoneal membrane failure","volume":"23","author":"Saxena","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1124\/jpet.114.215228_bib39","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/j.1582-4934.2011.01493.x","article-title":"Rapamycin inhibits transforming growth factor \u03b2-induced peritoneal angiogenesis by blocking the secondary hypoxic response","volume":"16","author":"Sekiguchi","year":"2012","journal-title":"J Cell Mol Med"},{"key":"10.1124\/jpet.114.215228_bib40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000326953","article-title":"Angiogenesis in peritoneal dialysis","volume":"34","author":"Stavenuiter","year":"2011","journal-title":"Kidney Blood Press Res"},{"key":"10.1124\/jpet.114.215228_bib41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cyto.2010.11.004","article-title":"Valsartan decreases TGF-\u03b21 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats","volume":"53","author":"Subeq","year":"2011","journal-title":"Cytokine"},{"key":"10.1124\/jpet.114.215228_bib42","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1161\/01.CIR.0000147233.10318.23","article-title":"Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction","volume":"110","author":"Sun","year":"2004","journal-title":"Circulation"},{"key":"10.1124\/jpet.114.215228_bib43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10157-011-0533-y","article-title":"Mechanisms and interventions in peritoneal fibrosis","volume":"16","author":"Tomino","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"10.1124\/jpet.114.215228_bib44","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/j.1523-1755.2004.00935.x","article-title":"TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model","volume":"66","author":"Yoshio","year":"2004","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.114.215228_bib46","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1681\/ASN.V132470","article-title":"Morphologic changes in the peritoneal membrane of patients with renal disease","volume":"13","author":"Williams","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.114.215228_bib47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J Pathol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524188507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524188507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.114.215228","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T22:35:28Z","timestamp":1743201328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524188507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0022356524188507"],"URL":"https:\/\/doi.org\/10.1124\/jpet.114.215228","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suramin Inhibits the Development and Progression of Peritoneal Fibrosis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.114.215228","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}